|
NR2C2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.219410E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.536100E-02 |
| Normal-vs-Stage2 |
7.021800E-01 |
| Normal-vs-Stage3 |
5.096700E-03 |
| Normal-vs-Stage4 |
1.811750E-02 |
| Stage1-vs-Stage2 |
6.481600E-01 |
| Stage1-vs-Stage3 |
1.422960E-01 |
| Stage1-vs-Stage4 |
1.722170E-01 |
| Stage2-vs-Stage3 |
1.504160E-01 |
| Stage2-vs-Stage4 |
1.701210E-01 |
| Stage3-vs-Stage4 |
6.402400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.487560E-01 |
| Normal-vs-AfricanAmerican |
1.593200E-01 |
| Normal-vs-Asian |
3.944500E-03 |
| Caucasian-vs-AfricanAmerican |
7.252200E-01 |
| Caucasian-vs-Asian |
2.692200E-01 |
| AfricanAmerican-vs-Asian |
2.998600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.670000E-02 |
| Normal-vs-Female |
7.162000E-01 |
| Male-vs-Female |
5.834000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.552300E-02 |
| Normal-vs-Extreme_Weight |
3.083000E-03 |
| Normal-vs-Obese |
7.049600E-01 |
| Normal-vs-Extreme_Obese |
4.144400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.270800E-01 |
| Normal_Weight-vs-Obese |
1.861640E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.573600E-01 |
| Extreme_Weight-vs-Obese |
3.869600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.451400E-01 |
| Obese-vs-Extreme_Obese |
5.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.446800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.049000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.309600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.962390E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.607600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.314400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.241900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.269700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.019700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.756400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.206200E-01 |
| Normal-VS-Type2 PRCC |
3.51289999978022E-07 |
| Normal-VS-KIRP CIMP |
1.700640E-01 |
| Normal-VS-Unclassified PRCC |
6.315800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.49189999979427E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.235200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.198000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.121780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.720200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.320400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.8657000000002E-05 |
| Normal-vs-N1 |
2.482300E-02 |
| Normal-vs-N2 |
2.542300E-03 |
| N0-vs-N1 |
4.967200E-01 |
| N0-vs-N2 |
3.751200E-01 |
| N1-vs-N2 |
3.238400E-01 |
|
|
